105 related articles for article (PubMed ID: 26950276)
1. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
2. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
3. Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia.
Shalek AK; Gaublomme JT; Wang L; Yosef N; Chevrier N; Andersen MS; Robinson JT; Pochet N; Neuberg D; Gertner RS; Amit I; Brown JR; Hacohen N; Regev A; Wu CJ; Park H
Nano Lett; 2012 Dec; 12(12):6498-504. PubMed ID: 23190424
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study.
Xue X; Wen Z; Zhang X; Yang Y; Li Y; Liao R; Zheng Q; Fu Y; Liu Y; Liao H
Genes Immun; 2024 Apr; 25(2):117-123. PubMed ID: 38366101
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL.
Largeot A; Klapp V; Viry E; Gonder S; Fernandez Botana I; Blomme A; Benzarti M; Pierson S; Duculty C; Marttila P; Wierz M; Gargiulo E; Pagano G; An N; El Hachem N; Perez Hernandez D; Chakraborty S; Ysebaert L; François JH; Cortez Clemente S; Berchem G; Efremov DG; Dittmar G; Szpakowska M; Chevigné A; Nazarov PV; Helleday T; Close P; Meiser J; Stamatopoulos B; Désaubry L; Paggetti J; Moussay E
Blood; 2023 Jun; 141(26):3166-3183. PubMed ID: 37084385
[TBL] [Abstract][Full Text] [Related]
6. LEF1 isoforms regulate cellular senescence and aging.
Jia M; Sayed K; Kapetanaki MG; Dion W; Rosas L; Irfan S; Valenzi E; Mora AL; Lafyatis RA; Rojas M; Zhu B; Benos PV
Aging Cell; 2023 Dec; 22(12):e14024. PubMed ID: 37961030
[TBL] [Abstract][Full Text] [Related]
7. CLLU1 as an emerging biomarker in chronic lymphoid leukemia.
Rong C; Liang C; Shen J; Zhang Y; Wang Q; Yang F; Chen Y; Luo Y; Gu M; Gao P; Xia Y; Duan S
Hum Cell; 2024 May; 37(3):625-632. PubMed ID: 38507118
[TBL] [Abstract][Full Text] [Related]
8. Expression of LEF1 in mantle cell lymphoma.
O'Malley DP; Lee JP; Bellizzi AM
Ann Diagn Pathol; 2017 Feb; 26():57-59. PubMed ID: 28038713
[TBL] [Abstract][Full Text] [Related]
9. Key roles of necroptotic factors in promoting tumor growth.
Liu X; Zhou M; Mei L; Ruan J; Hu Q; Peng J; Su H; Liao H; Liu S; Liu W; Wang H; Huang Q; Li F; Li CY
Oncotarget; 2016 Apr; 7(16):22219-33. PubMed ID: 26959742
[TBL] [Abstract][Full Text] [Related]
10. Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.
Wiernik PH
Expert Opin Investig Drugs; 2016 Jun; 25(6):729-34. PubMed ID: 26998706
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.
Berndt SI; Camp NJ; Skibola CF; Vijai J; Wang Z; Gu J; Nieters A; Kelly RS; Smedby KE; Monnereau A; Cozen W; Cox A; Wang SS; Lan Q; Teras LR; Machado M; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Vajdic CM; Cocco P; Zhang Y; Giles GG; Zeleniuch-Jacquotte A; Lawrence C; Montalvan R; Burdett L; Hutchinson A; Ye Y; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Cunningham JM; Allmer C; Hjalgrim H; Adami HO; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Arnett DK; Zhi D; Leach JM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Sala N; Casabonne D; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Chaffee KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Leis JF; Weinberg JB; Caporaso NE; Norman AD; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Masala G; Weiderpass E; Chirlaque MD; Vermeulen RCH; Travis RC; Southey MC; Milne RL; Albanes D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Villano DJ; Maria A; Spinelli JJ; Gascoyne RD; Connors JM; Bertrand KA; Giovannucci E; Kraft P; Kricker A; Turner J; Ennas MG; Ferri GM; Miligi L; Liang L; Ma B; Huang J; Crouch S; Park JH; Chatterjee N; North KE; Snowden JA; Wright J; Fraumeni JF; Offit K; Wu X; de Sanjose S; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Nat Commun; 2016 Mar; 7():10933. PubMed ID: 26956414
[TBL] [Abstract][Full Text] [Related]
12. Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation.
Zhao C; Deng Y; Liu L; Yu K; Zhang L; Wang H; He X; Wang J; Lu C; Wu LN; Weng Q; Mao M; Li J; van Es JH; Xin M; Parry L; Goldman SA; Clevers H; Lu QR
Nat Commun; 2016 Mar; 7():10883. PubMed ID: 26955760
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic and Leukemic Stem Cells Have Distinct Dependence on Tcf1 and Lef1 Transcription Factors.
Yu S; Li F; Xing S; Zhao T; Peng W; Xue HH
J Biol Chem; 2016 May; 291(21):11148-60. PubMed ID: 27044748
[TBL] [Abstract][Full Text] [Related]
14. Expression of C-X-C chemokine receptor type 7 in otorhinolaryngologic neoplasms.
Tang T; Xia QJ; Qiao X; Xi M
Singapore Med J; 2016 Mar; 57(3):157-60. PubMed ID: 26996902
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites.
Gao LM; Zhao S; Liu WP; Zhang WY; Li GD; Küçük C; Hu XZ; Chan WC; Tang Y; Ding WS; Yan JQ; Yao WQ; Wang JC
Am J Surg Pathol; 2016 Jun; 40(6):836-46. PubMed ID: 26975038
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of Wnt/β‑catenin target genes promotes proliferation and invasion of liver cancer stem cells.
Chen W; Zhang YW; Li Y; Zhang JW; Zhang T; Fu BS; Zhang Q; Jiang N
Mol Med Rep; 2016 Apr; 13(4):3466-74. PubMed ID: 26956539
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma.
Brot S; Cobb J; Alibhai AA; Jackson-Oxley J; Haque M; Patke R; Harris AE; Woodcock CL; Lothion-Roy J; Varun D; Thompson R; Gomes C; Kubale V; Dunning MD; Jeyapalan JN; Mongan NP; Rutland CS
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792023
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of New Cell Death Mechanisms in Leukemia.
Favale G; Donnarumma F; Capone V; Della Torre L; Beato A; Carannante D; Verrilli G; Nawaz A; Grimaldi F; De Simone MC; Del Gaudio N; Megchelenbrink WL; Caraglia M; Benedetti R; Altucci L; Carafa V
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730609
[TBL] [Abstract][Full Text] [Related]
20. Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent.
Yu L; Lee H; Rho SB; Park MK; Lee CH
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
